Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

65 results about "Intestinal tumor" patented technology

Intestinal tumors. The most common types of intestinal tumors include lymphoma, adenocarcinoma, and leiomyosarcoma. Approximately 70% adenocarcinoma tumors metastasize, and 30 to 50% of leiomyosarcoma tumors metastasize.

Control method of intestinal tumor resection robot combining preoperative image and intraoperative navigation

The invention provides a control method of an intestinal tumor resection robot combining preoperative images and intraoperative navigation, and relates to the technical field of medical instrument control. The method comprises the following steps: acquiring preoperative multi-modal image data of the intestinal tract of a patient, and performing three-dimensional reconstruction on the image data to generate an initial three-dimensional model; dividing a navigation area in the enteric cavity according to the initial three-dimensional model; based on the core area, collecting a dynamic image of the intestinal tract inner cavity in real time through intraoperative navigation equipment, extracting anatomical mark points in the dynamic image, registering the dynamic image with the initial three-dimensional model, updating tissue deformation parameters in the three-dimensional model, and obtaining an updated three-dimensional model; on the basis of the updated three-dimensional model, obstacles in the intestinal tract are recognized, and the minimum space distance between the obstacles and the robot tail end instrument is calculated; and according to the spatial distribution and the minimum spatial distance of the obstacles, an initial motion path of the robot tail end instrument is planned. According to the invention, the efficiency and accuracy of the intestinal tumor resection operation can be improved.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Ganoderma tsugae polysaccharide with effect of relieving colorectal cancer as well as preparation method and application of ganoderma tsugae polysaccharide

The invention discloses ganoderma tsugae polysaccharide with a colorectal cancer relieving effect and a preparation method and application thereof, and belongs to the technical field of biological medicine. The ganoderma tsugae polysaccharide is prepared from mannose, glucose, galactose and fucose, the molar ratio of the mannose to the glucose to the galactose to the fucose is 3.221 to 1.414 to 80.539 to 14.826, and the molecular weight of the ganoderma tsugae polysaccharide is 7.056 kDa. It is proved that the ganoderma tsugae polysaccharide can significantly reduce the number and size of colon tumors; the pathological symptoms such as colon weight index, bleeding, crypt budding, dysplasia and hyperplasia are relieved; compared with the prior art, the ganoderma tsugae polysaccharide provided by the invention has the advantages that the ganoderma tsugae polysaccharide can obviously inhibit the levels of IFN-gamma, TGF-beta and IL-17A in colon and also can obviously inhibit the levels of IFN-gamma, TGF-beta and IL-17A in colon, and meanwhile, the level of IL-4 is improved, so that the ganoderma tsugae polysaccharide provided by the invention has an outstanding action effect in the aspect of relieving colorectal cancer, and a theoretical support is provided for developing colorectal cancer medicines with effectiveness and biological safety.
Owner:JILIN AGRICULTURAL UNIV

Prediction system and method for postoperative cognitive impairment of gastrointestinal tumor surgery patient

ActiveCN120356679AImage enhancementMedical data miningPostoperative cognitive dysfunctionIntestinal tumor
The invention provides a postoperative cognitive impairment prediction system and method for gastrointestinal tumor surgery patients, and belongs to the technical field of postoperative cognitive impairment prediction of patients based on machine learning. The system comprises a data receiving and obtaining module, an abdomen CT feature extraction module, a patient clinical and information data coding module and a gastrointestinal tumor patient postoperative cognitive impairment prediction module. The data receiving and obtaining module extracts three-dimensional features of the abdomen image data to obtain an abdomen CT image fusion feature map; the patient clinical and information data coding module performs feature coding on the patient clinical data and the information data to obtain clinical feature vectors; and the gastrointestinal tumor patient postoperative cognitive impairment prediction module takes the abdominal CT image fusion feature map and the clinical feature vector as input and outputs a quantitative evaluation result of the postoperative cognitive impairment of the patient. According to the method, effective classification of cognitive impairment is realized, and powerful auxiliary support is provided for clinical intervention and management of postoperative patients.
Owner:NANCHANG UNIV

Culture system, culture method and application of gastrointestinal tumor organoid

The invention relates to the technical field of organoid culture, and relates to a culture system and a culture method for gastrointestinal tumor organoids for the first time, the culture system is formed by adding antioxidant active traditional Chinese medicine extracts such as naringin or polydatin on the basis of an existing culture system, when the culture system is used for culturing the gastrointestinal tumor organoid, the primary survival rate of the gastrointestinal tumor organoid and the proliferation rate after passage can be improved. Besides, the invention further provides application of the culture system of the gastrointestinal tumor organoid, the culture system and the cultured gastrointestinal tumor organoid are used for screening small-molecule targeted anti-tumor drugs, and a better in-vitro research model is provided for subsequent anti-tumor treatment.
Owner:NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A

Culture system, culture method and application of gastrointestinal tumor chemotherapy drug-resistant organoid

The invention discloses a culture system, culture method and application of gastrointestinal tumor chemotherapy drug-resistant organoid, the culture system comprises: a basic culture medium, which is a DMEM / F12 culture medium, and is additionally added with a special growth promoting factor obtained from a natural extract; the multiple growth factors comprise an epidermal growth factor (EGF), a fibroblast growth factor (FGF), a bone morphogenetic protein (BMP) and a vascular endothelial growth factor receptor inhibitor (VEGFRi), and the concentration of each growth factor is accurately screened and optimized; the extracellular matrix is Matrigel modified by physical and chemical methods; the specific additive comprises an antioxidant N-acetylcysteine (NAC). According to the culture system, the culture method and the application of the gastrointestinal tumor chemotherapy drug-resistant organoid, the culture system which is closer to a real environment in vivo is constructed by optimizing basic culture medium components, setting various growth factors and specific additive concentrations and adopting modified Matrigel as an extracellular matrix.
Owner:THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV

Gastrointestinal tumor chemotherapy risk scoring model and construction method thereof

The invention relates to the technical field of gastrointestinal tumor chemotherapy risk assessment, and particularly discloses a gastrointestinal tumor chemotherapy risk scoring model and a construction method thereof, and the method comprises the steps: obtaining the individualized feature data and basic physiological data of a historical patient, and constructing an individualized difference library with a unique ID, and a core influence library; the method comprises the following steps: standardizing and coding double-library data, synchronizing clinical data containing treatment effect codes, forming a data dictionary, acquiring and coding current gastrointestinal tumor patient data, and matching the data dictionary to judge individual difference abnormity; when the first data set is abnormal, constructing a first data set, screening core independent variables through Logistic regression, and constructing a scoring model by using an LSTM (Long Short Term Memory) model; when no abnormity exists, redundant codes are removed to obtain a second data set, and modeling is conducted through the same method. Through double-library linkage and scene-divided modeling, the three-level toxicity risk prediction precision is improved, data support is provided for clinical chemotherapy dose adjustment and toxicity prevention, and the risk of excessive treatment or insufficient treatment is reduced.
Owner:FIRST AFFILIATED HOSPITAL OF GANNAN MEDICAL UNIV

Robot guiding path optimization method and system for gastrointestinal tumor assisted surgery

The invention discloses a robot guide path optimization method and system for gastrointestinal tumor assisted surgery, particularly relates to the technical field of robot assisted navigation, and is used for solving the problem of unstable and inaccurate path planning. According to the method, fusion of multi-modal information under the unified time and space is achieved through space-time alignment of a preoperative model and intraoperative perception data, registration uncertainty and visibility indexes are dynamically calculated, and the fusion of the multi-modal information under the unified time and space is achieved through construction of an anatomical risk layer, a forbidden zone, geometric stenosis, perfusion evidence, a collision distance margin and a puncture point remote rotation center constraint satisfaction degree. A multi-channel path cost graph is generated, the safety of the path is evaluated, a constraint propagation and regulation causal graph mechanism is combined, a conflict solution contribution degree and a path optimization priority sequence can be rapidly output, it is ensured that the robot executes the optimal path in a complex anatomical environment, a conservative mode is switched when a key risk index triggers a threshold value, and the optimal path is obtained. Real-time regulation and control and safety guarantee are achieved, and the stability of the operation process is improved.
Owner:南昌大学第一附属医院

Intestinal tumor risk assessment method based on image analysis

The invention relates to the technical field of tumor risk assessment, in particular to an intestinal tumor risk assessment method based on image analysis, and the method comprises the steps: carrying out the continuous image division and parameter collection; identifying abnormal density image blocks; identifying concerned risk image blocks; judging a response risk image block; adjusting a preset synchronization degree risk threshold value; early warning judgment is carried out, and a serious early warning report is generated. According to the method, a self-adaptive and dynamically-adjusted three-level judgment system is established through real-time collaborative analysis of multi-dimensional parameters of an enteroscope image block, firstly, a suspected focus is locked based on the texture change duration, then, the focus characteristics are verified through vascular abnormality and contrast fluctuation depth, and finally, the accuracy of the focus is improved. And finally, the risk threshold is corrected in combination with intestinal wall peristalsis and the lens shielding degree, so that the problem of low early flat tumor recognition accuracy caused by insufficient flat tumor image feature capture due to excessive dependence on intestinal environment microorganism and metabolite biochemical detection is effectively solved.
Owner:SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG PROVINCIAL HOSPITAL)

A robotic guidance path optimization system for gastrointestinal tumor assisted surgery

This invention discloses a robot-guided path optimization system for assistive surgery in gastrointestinal tumors, specifically relating to the field of robot-assisted navigation technology, to address the problem of unstable and inaccurate path planning. This invention achieves spatiotemporal alignment of preoperative models and intraoperative sensory data, fusing multimodal information in a unified time and space. It dynamically calculates registration uncertainty and visibility indices, constructs anatomical risk layers, no-entry zones, geometric stenosis, perfusion evidence, collision distance margin, and remote rotation center constraint satisfaction at the puncture point, and generates a multi-channel path cost graph to assess path safety. Combined with constraint propagation and causal graph control mechanisms, it can quickly output conflict resolution contribution and path optimization priority sequences, ensuring the robot executes the optimal path in complex anatomical environments. When key risk indicators trigger thresholds, it switches to a conservative mode, achieving real-time control and safety assurance, and improving the stability of the surgical procedure.
Owner:南昌大学第一附属医院

Mouse intestinal tumor cell injector

The mouse intestinal tumor cell injector comprises a handle, an injection device installed in the handle, and a radially telescopic support ring structure connected with the handle, tumor cells can be discharged from a first injection needle by operating a first push rod, and antibiotics can be discharged from a second injection needle by operating a second push rod; when the support ring structure is in a contracted state, the first injection needle and the second injection needle are located in the support ring structure; when the support ring structure is in an expanded support state, the needle heads of the first injection needle and the second injection needle can both extend to the outside of the outer edge of the support ring structure and are inserted into the mouse intestinal wall. The present application supports the mouse intestine by the support ring structure, supports the insertion of the first injection needle and the second injection needle into the mouse intestinal wall, ensures that only the mouse intestinal endothelium is punctured and the mouse intestinal canal is not punctured, ensures that tumor cells are injected into the mouse intestinal wall, and when the tumor cells are injected, antibiotics are also injected for anti-inflammatory treatment, which is beneficial to the recovery of the mouse intestinal puncture point.
Owner:CHINESE PEOPLES LIBERATION ARMY ARMY SPECIAL MEDICAL CENTER

Single-cell lineage tracking, temporal recording, and crispr screening platform

Disclosed herein is a custom platform called NSC-seq that can be used for cell lineage and cell division tracking in a temporal fashion but also with single-cell resolution. With simultaneous integration of single-cell transcriptomics with lineage barcoding and temporal recording information, NSC-seq facilitates the generation of multidimensional datasets for elucidating functional heterogeneity and clonal events in vivo. We apply this platform (i) to decipher lineage branching of mouse embryonic development, (ii) to record clonal dynamics of the adult intestinal epithelium, and (iii) to track clonal composition of the mouse intestinal tumors. In addition, we apply NSC-seq to assess a comprehensive gene expression phenotype for individual gene knockout at the single-cell level using existing whole-genome CRISPR knockout screening plasmid libraries. Overall, NSC-seq enables in vivo temporal recording of mammalian development and cancer at single-cell resolution.
Owner:VANDERBILT UNIV

Intelligent evaluation system for gastrointestinal tumor minimally invasive diagnosis and treatment data based on deep learning

The present application relates to gastrointestinal tumor minimally invasive diagnosis and treatment data intelligent evaluation technical field, specifically to gastrointestinal tumor minimally invasive diagnosis and treatment data intelligent evaluation system based on deep learning, system includes lesion perception module tracking abnormal edge and describing moving path, evolution sketch module extracts direction change to express evolution order, stage interpretation module contrasts guide feature and makes clear stage attribution, diagnosis and treatment mapping module combines operation time sequence to make clear stage and operation order, evaluation convergence module is associated with whole process data, generates gastrointestinal tumor minimally invasive diagnosis and treatment data intelligent evaluation result.The present application, through the relationship between the displacement of the lesion boundary and the direction evolution, makes the lesion change present a continuous evolution process, uses the sequential expression feature to make clear the stage direction, corresponds the image evolution and the diagnosis and treatment semantics to establish the judgment basis, associates the lesion evolution and the operation behavior on the unified time axis to form consistent mapping, thereby improves the coherent expression and the explanation of diagnosis and treatment, enhances the support value of evaluation result.
Owner:HANZHONG CENT HOSPITAL

Recombinant clostridium praeparatum fpPRPS protein as well as preparation method and application thereof

The invention discloses a recombinant clostridium praeparatum fpPRPS protein, the amino acid sequence of the recombinant protein is shown as SED ID No.3, and the nucleotide sequence of a gene for coding the recombinant protein is shown as SED ID No.2. The invention further discloses a preparation method of the recombinant clostridium praeparatum fpPRPS protein. Experiments prove that the recombinant clostridium praeparatum fpPRPS protein prepared by the invention has effective anti-inflammatory and anti-tumor components, and is simple to prepare, good in activity, high in purity, low in toxicity and easy to popularize and apply clinically and commercially; the invention has important significance for effectively treating and relieving intestinal inflammation and occurrence of various tumors including intestinal tumors and treating various Th17-related inflammations or tumors.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Gastrointestinal tumor size measuring device under endoscope

The invention relates to the technical field of gastrointestinal tumor detection, in particular to a gastrointestinal tumor size measuring device under an endoscope, which comprises an endoscope body, and a camera for acquiring image information in real time is arranged in the endoscope body; a grid forming assembly is arranged at one end, close to the camera, of the endoscope body; the grid forming assembly comprises a plurality of fixing blocks which are arranged in the circumferential direction with the endoscope body as the center, a plurality of extension mechanisms are fixedly connected to the fixing blocks, a testing rope is connected between the extension mechanisms located on the same horizontal line or the same vertical line, a plurality of evenly-arranged LED lamps are arranged on the testing rope, and the adjacent LED lamps are connected through electric wires; the extension mechanism is electrically connected with a control panel used for controlling the extension mechanism to work so as to adjust the length of the test rope, a tensioning mechanism used for tensioning the test rope is arranged in the endoscope body, and the control panel is electrically connected with the camera and the tensioning mechanism; the gastrointestinal tumor detector is simple to operate, can more accurately measure the size of gastrointestinal tumor, and is convenient for doctors to diagnose.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Pharmaceutical composition for treating or preventing at least one disease selected from group consisting of inflammatory bowel disease and intestinal tumor

A pharmaceutical composition for treating or preventing at least one disease selected from the group consisting of inflammatory bowel diseases and intestinal tumors, the pharmaceutical composition comprising: an inhibitor of binding between a dendritic cell immune receptor and a double-stranded sialic acid N-type sugar chain, or a dendritic cell immune receptor inhibitor; and a pharmaceutically acceptable carrier.
Owner:公益财团法人路易·巴斯德医学研究中心

Use of lactobacillus rhamnosus AFY01 and product thereof in inflammatory colon cancer

The present invention belongs to the field of microorganisms, and specifically relates to the use of Lactobacillus rhamnosus AFY01 and a product thereof in inflammatory colon cancer. Provided is a strain of Lactobacillus rhamnosus AFY01 with the deposit number of CGMCC No. 27362. The AFY01 can effectively alleviate weight loss in mice with colon cancer and colon shortening caused by intestinal inflammation and edema, reduce the colon coefficient of mice, reduce the visceral index and reduce the occurrence of intestinal tumors in mice, alleviate intestinal inflammation, and promote intestinal tumor cell apoptosis to slow down the development of colon cancer. By means of the present invention, the strain resources are expanded, thus providing technical support for the prevention and treatment of intestinal cancers.
Owner:CHONGQING UNIV OF EDUCATION

A polysaccharide of taxodin ganoderma lucidum with efficacy of relieving colorectal cancer and a preparation method and application thereof

This invention discloses a polysaccharide from *Ganoderma lucidum* (also known as *Ganoderma lucidum* or *Ganoderma sinense*) with efficacy in alleviating colorectal cancer, its preparation method, and its applications, belonging to the field of biomedical technology. The polysaccharide is composed of mannose, glucose, galactose, and fucose, with a molar ratio of 3.221:1.414:80.539:14.826 and a molecular weight of 7.056 kDa. It has been confirmed that the polysaccharide can significantly reduce the number and size of colon tumors; alleviate pathological symptoms such as colonic weight index, bleeding, crypt budding, dysplasia, and hyperplasia; and significantly inhibit the levels of IFN-γ, TGF-β, and IL-17A in the colon while increasing the level of IL-4. Therefore, the polysaccharide provided by this invention has a significant effect in alleviating colorectal cancer, and this invention provides theoretical support for the development of effective and biosafe colorectal cancer drugs.
Owner:JILIN AGRICULTURAL UNIV

Evaluation method of intestinal anastomosis stent

According to the evaluation method of the intestinal anastomosis stent, the implantation environment of the intestinal anastomosis stent after the intestinal tumor operation of a patient is simulated by establishing a mechanical intestinal obstruction animal model. It is observed that in digestive tract anastomosis after intestinal tract dissection under the intestinal obstruction animal model, wound healing of the intestinal tract anastomotic stoma can be promoted through implantation of the anastomosis stent, the abdominal cavity adhesion degree is reduced in the healing process, and the intestinal tract bursting pressure strength recovery is good; meanwhile, according to tissue slice analysis of the part, it can be seen that the tissue healing process conforms to the physiological healing rule and is superior to the healing condition of a stent-free implantation group. From indexes such as expression of inflammation degree, expression of new vessels, fibrosis degree and the like, whether the healing promoting effect of the stent to be detected after intestinal anastomosis under the mechanical intestinal obstruction animal model has obvious advantages or not can be judged through comparison of a stent implantation group and a stent-free implantation group. The invention provides a visual detection method for evaluating the intestinal anastomosis stent prepared from a new material.
Owner:WENZHOU AOTONG MEDICAL TECHNOLOGY CO LTD

Rectal tumor image segmentation method and device

The application provides a rectal tumor image segmentation method and device, which can be applied to the technical field of medical image processing. The method comprises the following steps: performing image segmentation on a magnetic resonance image by using a segmentation block in a target segmentation model to obtain an initial segmentation image, wherein the magnetic resonance image is obtained by scanning a rectal region of a target object by an imaging device in a first medical institution, the labeling accuracy of the rectal tumor region in the initial segmentation image does not meet a segmentation accuracy condition, and the training sample of the target segmentation model is obtained by scanning by an imaging device in a second medical institution; performing image segmentation on the magnetic resonance image by using a general segmentation model by fusing the magnetic resonance image and the initial segmentation image to output a corrected segmentation image; performing feature extraction on the corrected segmentation image by using a feature extraction block of the target segmentation model to obtain corrected image features; and performing image segmentation on the magnetic resonance image according to the corrected image features by using the segmentation block to obtain a target segmentation image that meets the segmentation accuracy condition.
Owner:UNIV OF SCI & TECH OF CHINA

A culture system, culture method and application of gastrointestinal tumor organoids

The present invention relates to the technical field of organoid culture, and for the first time relates to a culture system and a culture method for gastrointestinal tumor organoids. The culture system is composed of adding antioxidant active traditional Chinese medicine extracts such as naringin or polydatin to the existing culture system. Using this culture system to culture gastrointestinal tumor organoids can improve the primary survival rate and the proliferation rate after passage of the gastrointestinal tumor organoids. In addition, the present invention also provides an application of the culture system for gastrointestinal tumor organoids, using the culture system and the gastrointestinal cancer organoids cultured thereby to perform drug screening on small molecule targeted anti-tumor drugs, providing a better in vitro research model for subsequent anti-tumor treatment.
Owner:NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A

Composition for treating colon neoplasms by intraluminal application of antibiotics

PendingKR1020260139789AOncologyAdenoma
The present invention provides a composition comprising fosfomycin for reducing or removing bacterial promoting factors of colorectal cancer from colorectal adenomas, polyps, and adenocarcinomas, as well as from associated bacterial biofilms, by local administration into the intestinal lumen.
Owner:레포넥스 파마슈티컬스 에이에스

Lacticaseibacillus rhamnosus AFY01 and application of product prepared from lacticaseibacillus rhamnosus AFY01 in inflammatory colon cancer

Lacticaseibacillus rhamnosus AFY01 and an application of a product prepared from Lacticaseibacillus rhamnosus AFY01 in inflammatory colon cancer are provided, which relates the field of microbes. A preservation number of the Lacticaseibacillus rhamnosus AFY01 is CGMCC No. 27362. The Lacticaseibacillus rhamnosus AFY01 can effectively alleviate weight loss, intestinal inflammation and edema induced colon shortening in mice with colon cancer, reduce colon coefficient, visceral index and incidence of intestinal tumors in mice, improve intestinal inflammation, promote apoptosis of intestinal tumor cells to slow down the development of colon cancer. The Lacticaseibacillus rhamnosus AFY01 expands bacterial resources to provide technical support for the prevention and treatment of colorectal cancer.
Owner:CHONGQING UNIV OF EDUCATION

Cell culture device for stem cell detection of gastrointestinal tumor

The invention discloses a cell culture device for stem cell detection of gastrointestinal tumor, and particularly relates to the technical field of cell culture.The cell culture device mainly comprises a rectangular frame column and a linkage screw, the linkage screw is located in the rectangular frame column and rotationally connected with the rectangular frame column, and the top end of the rectangular frame column is fixedly connected with a gear motor used for driving the linkage screw to rotate; a layered linkage mechanism is arranged on the outer wall of the linkage screw rod; the layered linkage mechanism comprises a plurality of sleeving sliding blocks arranged on the outer wall of the linkage screw. A layered linkage mechanism is adopted to start a gear motor to drive a linkage screw to rotate reversely, a concave block enables a connecting shaft to drive an inclined sleeve rod to move upwards, a sealing rotary disc is far away from an arc-shaped limiting plate along the top end of a culture disc, and the top ends of multiple culture dish groove bodies are synchronously opened; the plurality of gastrointestinal tumor stem cell culture dishes in the culture box can be quickly uncovered and checked, and the culture of the gastrointestinal tumor stem cells is more time-saving and labor-saving.
Owner:GUANGZHOU MERCURY BIOMEDICAL TECHNOLOGY CO LTD

A device for filtering and collecting waste fluid from peritoneal lavage during gastrointestinal tumor surgery.

This invention belongs to the field of medical device technology and relates to a filtration and collection device for peritoneal lavage waste fluid during gastrointestinal tumor surgery. It includes a coarse filtration section, a reaction chamber, and a collection section connected in sequence. The reaction chamber comprises a cavity body, a micropillar array, an electromagnet array, and a fibrin network. An annular inlet is located in the center of the cavity body. The micropillar surfaces are modified with anti-CD45 antibodies; the electromagnet array generates a magnetic field pointing towards the bottom of the cavity body; the fibrin network fills the gaps between the micropillars, and anti-CD45 immunomagnetic beads are exposed on the pore surface of the fibrin network. Gold nanoparticles and thermosensitive liposomes are dispersed within the fibrin network, and plasmin is encapsulated within the thermosensitive liposomes. During use, the anti-CD45 immunomagnetic beads capture leukocytes; the complex is attracted to the micropillar surface by the magnetic field and captured; fat is trapped by the fibrin network; tumor cells pass through the fibrin network into the collection section; and photo-triggered degradation releases the magnetic beads, leukocyte complex, and fat, thus resolving the contradiction between the trapping and clogging of fixed-pore size filters.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL OF JILIN UNIV

Probiotics for preventing, treating or adjunctively treating colorectal cancer and application thereof

The invention provides probiotics for preventing, treating or adjunctively treating colorectal cancer and application of the probiotics, and relates to the technical field of microorganisms. The invention provides lactobacillus plantarum, in particular to lactobacillus plantarum KSFY202401, which is preserved in the General Microbiological Center of the China Committee for Culture Collection of Microorganisms, and the preservation number is CGMCC NO.30984. The lactobacillus plantarum has the advantages that the lactobacillus plantarum is prepared from lactobacillus plantarum, lactobacillus plantarum KSFY202401 and lactobacillus plantarum KSFY202401; the lactobacillus plantarum KSFY202401 provided by the invention plays a remarkable role in interfering the occurrence and development of colorectal cancer, and plays a role in slowing down the development of colorectal cancer by improving intestinal inflammation and promoting the apoptosis of intestinal tumor cells. The lactobacillus plantarum KSFY202401 provides scientific evidence for the healthy function of the lactobacillus plantarum KSFY202401 on intestinal tracts, and provides more scientific basis for prevention and adjuvant therapy of colorectal cancer from the diet aspect.
Owner:THANKCOME BIOLOGICAL SCI & TECH CO LTD

Colorectal cancer biomarkers and their applications in diagnosis, prevention, treatment and prognosis

The present invention discloses colorectal cancer biomarkers and their applications in diagnosis, prevention, treatment, and prognosis. The present invention also discloses distinct single-cell characteristics of blood and intestinal ILCs subsets under healthy conditions and in the setting of colorectal cancer. The healthy intestine is composed of ILC1s, ILC3s, and ILC3s / NK cells, but lacks ILC2s. Additional tumor-specific ILC1s and ILC2s subsets were identified in CRC patients. The present invention also discloses that SLAMF1 is selectively expressed on tumor-specific ILCs, and higher levels of SLAMF1+ ILCs are observed in the blood of CRC patients. The survival rate of rectal cancer patients with high SLAMF1 expression was significantly higher than that of those with low SLAMF1 expression, indicating that SLAMF1 is an anti-tumor biomarker in CRC. The present invention also discloses the use of unsupervised hierarchical clustering methods to investigate the heterogeneity of auxiliary ILCs in blood, normal mucosa, and intestinal tumors during steady state and CRC. These biomarkers can effectively diagnose, prevent, treat, assess prognosis, and predict survival for CRC.
Owner:SHANGHAI INST OF IMMUNOLOGY +4

Preparation method and application of a rapid photodynamic therapy for tumors based on plant-derived carbon dots.

PendingCN123101675AHemolysisSuperoxide
This invention discloses a method for preparing and applying a rapid photodynamic therapy formulation for tumor treatment based on plant-derived carbon dots. The photodynamic therapy formulation comprises plant-derived carbon dots prepared from natural plant leaves. These carbon dots can rapidly generate reactive oxygen species under 660 nm laser irradiation, inducing tumor cell apoptosis with only one minute of light exposure. The plant-derived carbon dots of this invention exhibit good biocompatibility, low hemolysis rate, and no significant photothermal effect. They can efficiently generate various reactive oxygen species, including singlet oxygen, superoxide anion, and hydroxyl radicals. In vivo animal experiments have confirmed that short-term light exposure can inhibit colon tumor proliferation and promote tumor apoptosis, with no significant toxic side effects on major organs. This formulation can be used to prepare tumor photodynamic therapy drugs, especially suitable for rapid photodynamic anti-tumor treatment, and also possesses good storage stability, showing broad application prospects in the fields of tumor treatment and photodynamic drugs.
Owner:JIANGSU JINGSHUO LINGZHI OPTOELECTRONICS TECHNOLOGY CO LTD

A rectal and anal exercise device for rectal tumor care

PendingCN123101373AButtocksSphincter
This invention discloses a rectal and anal exercise device for rectal tumor care, comprising: a base plate with a support sleeve fixedly connected to its top; and a support fixedly connected to the top of the support sleeve, the top of which is configured with a concave arc-shaped structure and rectangular holes on both sides. Through a series of structures, this invention enables the elastic pressure ball to provide supportive compression to the area around the anus during the reciprocating lifting and lowering of the lifting plate, simultaneously driving the anal pressure airbag to extend to the corresponding position of the anus, forming a continuous stimulation process of progressive pressure from the periphery to the center; simultaneously, it provides auxiliary inward compression to both sides of the buttocks, thereby effectively linking local progressive stimulation with bilateral auxiliary inward contraction, helping patients with weak anal sphincter muscles or difficulty in initiating contraction to more accurately complete the anal sphincter contraction action; compared with traditional insertive training methods, it can reduce local discomfort and psychological resistance, and improve training compliance.
Owner:THE FIRST AFFILIATED HOSPITAL OF HEBEI NORTH UNIV

Intestinal tumor suppressor, pge2 production inhibitor, and il-22bp production promoter

An intestinal tumor suppressor that contains a Dectin-1 inhibitor or a β-glucan having a Dectin-1 inhibitory activity and that suppresses an intestinal tumor through Dectin-1 inhibition; a PGE2 production inhibitor that contains a β-glucan having a Dectin-1 inhibitory activity; and an IL-22BP production promoter containing a β-glucan having a Dectin-1 inhibitory activity, are provided.
Owner:LOUIS PASTEUR CENT FOR MEDICAL RES

Use of WAY-262611 in the manufacture of a medicament for the treatment of inflammatory bowel disease

The present application relates to the field of biological medicine, and particularly relates to the use of WAY-262611 or a pharmaceutically acceptable salt thereof in the treatment of inflammatory bowel disease. The present application has the beneficial effect that the use of WAY-262611 or a pharmaceutically acceptable salt thereof in improving the symptoms of inflammatory bowel disease in mice and reducing intestinal damage is discovered and verified for the first time, can significantly promote the proliferation and repair of intestinal epithelial cells in mice, and has outstanding effects in reducing the incidence of intestinal tumors caused by inflammatory bowel disease.
Owner:SHANGHAI BAOSHAN DISTRICT INTEGRATED TRADITIONAL & WESTERN MEDICINE HOSPITAL